Account Management Director, Advanced Therapies; Cell and Gene Therapy

Position Overview

Expand relationships that accelerate next‑generation therapies. As FUJIFILM Biotechnologies’ Account Director for Advanced Therapies, you will unlock growth across a portfolio of strategic biopharma accounts—expanding scope, deepening partnerships, and aligning our global network’s capabilities to program needs. You’ll operate across FUJIFILM Biotechnologies and the broader FUJIFILM Life Sciences Cell Therapy network (including FUJIFILM Biotechnologies California and FUJIFILM Cellular Dynamics), translating opportunity into impact for patients and measurable top‑line growth.

Be a Partner for Life – Champion a lifecycle partnership model that ensures seamless tech transfer across sites and phases, proactive capacity and scenario planning, and phase-appropriate solutions that de‑risk timelines, scale reliably, and instill trust with our Customers.

The work we do at FUJIFILM Biotechnologies has never been more important—and we are looking for talented candidates to join us. We are growing our locations, our capabilities, and our teams, and looking for passionate, mission‑driven people like you who want to make a real difference in people’s lives. Join FUJIFILM Biotechnologies and help make the next vaccine, cure, or gene therapy in partnership with some of the most innovative biopharma companies across the globe.

We are proud to cultivate a culture that will fuel your passion, energy, and drive - what we call Genki.

Fujifilm is globally headquartered in Tokyo with over 70,000 employees across four key business segments of healthcare, electronics, business innovation, and imaging. We are guided and united by our Group Purpose of “giving our world more smiles.” Visit:

What you’ll do

• Own retention and expansion:
  Deliver net revenue retention and expansion targets within a defined portfolio; identify whitespace and drive cross‑sell/upsell across the CGT value chain.
• Lead executive account strategy:
  Build multi‑year account plans and QBRs with R&D, CMC, MSAT, QA/RA, Procurement, and Legal stakeholders; establish executive sponsorship and governance.
• Translate science to value:
  Position capabilities spanning process and analytical development, tech transfer, scale‑up, GMP manufacturing, QC/release testing, comparability, and PPQ.
• Navigate complex commercial constructs:
  Shape and negotiate MSA/SOW/QoA, pricing frameworks, and change controls; align scope, risk, and timelines with capacity and quality requirements.
• Drive disciplined execution:
  Maintain accurate forecasts, pipeline hygiene, and stage conversion; keep systems and leadership current with data‑driven updates and risks/mitigations.
• Represent the brand:
  Lead presence at priority conferences and trade shows; convert visibility into qualified expansion opportunities.
• Partner for delivery:
  Work closely with Program Management and sites to ensure proactive communication, on‑time milestones, and high sponsor satisfaction; anticipate capacity needs with Demand Planning.
• Capture the voice of the customer:
  Provide structured feedback to inform solution roadmaps, differentiation, and win rates.

• Modalities and platforms: AAV and Lentiviral vectors; iPSC/PSC‑derived cells; immune cell therapies (e.g., NK/T); plasmid and mRNA; upstream/downstream PD/AD and scale‑up.
• CMC/GMP fluency:
  Phase‑appropriate development from pre‑IND to BLA;
  QbD principles; tech transfer, comparability, PPQ; QC methods, release/stability; change control and deviations.
• CGT operations:
  Chain of identity and chain of custody integrity; cryopreservation and cold‑chain logistics; audit readiness and regulatory expectations.
• Enterprise buying dynamics:
  Comfort influencing multi‑stakeholder decisions across…